Physician
Mcgranahan, Mark
Mcgranahan, Mark was paid $585K by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider infoMCGRANAHAN, MARK
CASEYVILLE, IL 62232
CASEYVILLE, IL 62232
33aNPI1215922000assigned 09/16/2005
33bProvider typePediatrics Physician
28Total paid$585K
24GClaims12,132
24DCodes billed34
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#258 of 1,805
Median peer was paid$55K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 925 | $44K | |
| 2019 | 1,400 | $54K | |
| 2020 | 1,058 | $46K | |
| 2021 | 2,427 | $112K | |
| 2022 | 2,438 | $124K | |
| 2023 | 2,000 | $100K | |
| 2024incomplete | 1,884 | $104K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 3,475 | 2,986 | $171K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 1,622 | 1,436 | $128K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13% | 1,509 | 1,301 | $77K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 822 | 674 | $63K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.4% | 633 | 528 | $43K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.1% | 476 | 393 | $36K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.0% | 150 | 117 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 623 | 569 | $10K |
| 90686 | 1.3% | 667 | 606 | $7K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 119 | 96 | $5K |
| 87428 | <1% | 76 | 70 | $5K | |
| 90670 | <1% | 295 | 244 | $5K |
22 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 246 | $4K |
| 99252 | <1% | 104 | $4K | |
| 90677 | <1% | 34 | $3K | |
| 96127 | <1% | 184 | $3K | |
| 90661 | <1% | 80 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 74 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 16 | $1K |
| 90723 | <1% | 78 | $906.11 | |
| 90647 | <1% | 62 | $761.67 | |
| 36416 | <1% | 196 | $751.12 | |
| 0071A | <1% | 19 | $674.24 | |
| 0001A | <1% | 15 | $632.10 | |
| 0002A | <1% | 14 | $589.96 | |
| 87807 | <1% | 58 | $583.48 | |
| 94760 | <1% | 335 | $447.81 | |
| 90680 | <1% | 41 | $399.63 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $333.45 |
| 83655 | <1% | 24 | $284.64 | |
| 90633 | <1% | 22 | $140.80 | |
| 90648 | <1% | 13 | $83.20 | |
| 91300 | <1% | 22 | $22.67 | |
| 91307 | <1% | 15 | $0.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.